HighTower Advisors’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.89M Buy
10,129
+478
+5% +$127K ﹤0.01% 1262
2026
Q1
$1.06M Sell
9,651
-2,574
-21% -$367K ﹤0.01% 2142
2025
Q4
$2.03M Buy
12,225
+592
+5% +$99K ﹤0.01% 1656
2025
Q3
$2.28M Sell
11,633
-330
-3% -$54.3K ﹤0.01% 1560
2025
Q2
$1.08M Buy
11,963
+2,812
+31% +$222K ﹤0.01% 1957
2025
Q1
$546K Buy
9,151
+2,956
+48% +$273K ﹤0.01% 2385
2024
Q4
$821K Buy
+6,195
New +$581K ﹤0.01% 2111

Other funds holding ALAB

HighTower Advisors's ALAB Position: Q2 2026 in Review

HighTower Advisors increased its Astera Labs (ALAB) stake by 5% in Q2 2026, buying an estimated $127K and bringing the position to 10,129 shares worth $4.89M. The position accounts for ﹤0.01% of the portfolio, ranked #1262.

HighTower Advisors first reported a position in ALAB in Q4 2024 and has held it in 7 quarters since. 989 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • HighTower Advisors held 10,129 shares of Astera Labs worth $4.89M as of Q2 2026.
  • HighTower Advisors bought 478 Astera Labs shares in Q2 2026, an estimated $127K.
  • Astera Labs made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #1262 holding.
  • HighTower Advisors first reported a position in Astera Labs in Q4 2024 and has held it in 7 quarters since.
  • 989 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.